Page 46 - Technical Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Data Suggests Phase-3 Trials For Covid Drug 2-DG May Continue Till August Data Suggests Phase-3 Trials For Covid Drug 2-DG May Continue Till August The third-phase trials began in January, while the phase-2 trials were conducted over a three-month period between June and September last year and involved 110 patients. 2-DG has been studied in more than 200 clinical trials for the treatment of various cancers globally. New Delhi: With the government presenting DRDO-developed drug 2-DG as a potential game-changer in the fight against COVID-19, the clinical trial registry data suggests that ...

With the government presenting DRDO-developed drug 2-DG as a potential game-changer in the fight against COVID-19, the clinical trial registry data suggests that the phase-3 trials for the medicine at over two dozen government and private hospitals and involving 220 patients may continue till August. The third-phase trials began in January, while the phase-2 trials were conducted over a three-month period between June and September last year and involved 110 patients. While 2-DG has been studied in more than 200 clinical trials for the treatment of various cancers globally, trials to use i...

The third-phase trials began in January, while the phase-2 trials were conducted over a three-month period between June and September last year and involved 110 patients.

Following the signing of a trade agreement in April between the United Kingdom and Serbia, the British-Serbian Chamber of Commerce, in partnership with Emerging Europe, organised an online seminar — the first in a series — focused on joint business opportunities for British and Serbian companies. The online webinar began with a fireside chat between […]

May 17, 2021 “Saveetha Hospital is managing one of the highest numbers of COVID-19 patients among the private hospitals in the country. The hospital has successfully treated more than 6500 patients so far. The hospital has allocated 500 COVID beds, which includes 250 oxygen beds, 50 COVID ICU beds and 80 HDU beds with occupancy of nearly 100% in the second wave. The hospital has managed more than 900 critically ill patients in the COVID ICU, and is running a successful ECMO program for COVID patients,” said Dr. N.M. Veeraiyan, Founder and Chancellor SIMATS. The COVID patients are managed ...